IL‐25 exhibits disparate roles during Th2‐cell differentiation versus effector function
Open Access
- 15 April 2014
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 44 (7) , 1976-1980
Abstract
A keenly sought therapeutic approach for the treatment of allergic disease is the identification and neutralization of the cytokine that regulates the differentiation of T helper 2 (Th2) cells. Th2 cells are exciting targets for asthma therapies. Recently, the cytokine IL‐25 has been shown to enhance Th2‐type immune activity and play important roles in mediating allergic inflammatory responses. To investigate this further, we crossed IL‐25−/− C57BL/6 mice with G4 IL‐4 C57BL/6 reporter mice and developed an assay for in vitro and in vivo IL‐4‐independent Th2‐cell differentiation. These assays were used to determine whether IL‐25 was critical for the formation of Th2 cells. We found there was no physiological role for IL‐25 in either the differentiation of Th2 cells or their development to effector or memory Th2‐cell subsets. Importantly, this data challenges the newly found and growing status of the cytokine IL‐25 and its proposed role in promoting Th2‐cell responses.Keywords
Funding Information
- Health Research Council of New Zealand and the Marjorie Barclay Trust
This publication has 17 references indexed in Scilit:
- Nuocytes represent a new innate effector leukocyte that mediates type-2 immunityNature, 2010
- In vivostudies fail to reveal a role for IL-4 or STAT6 signaling in Th2 lymphocyte differentiationProceedings of the National Academy of Sciences, 2008
- IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC–activated Th2 memory cellsJournal of Experimental Medicine, 2007
- Interleukin 25 promotes the initiation of proallergic type 2 responsesJournal of Experimental Medicine, 2007
- Mechanism of interleukin‐25 (IL‐17E)‐induced pulmonary inflammation and airways hyper‐reactivityClinical & Experimental Allergy, 2006
- Identification of an interleukin (IL)-25–dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsionJournal of Experimental Medicine, 2006
- Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tractJournal of Experimental Medicine, 2006
- IL-25 Induces IL-4, IL-5, and IL-13 and Th2-Associated Pathologies In VivoImmunity, 2001
- Analysis of Type 2 Immunity In Vivo with a Bicistronic IL-4 ReporterImmunity, 2001
- Regulation of Expression of IL-4 AllelesImmunity, 2001